Approval · Notice of Compliance 16795 · 2015
ESTRACE: Notice of Compliance 16795
Issued April 14, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16795
- Date
- April 14, 2015
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Estrogen